Loss of heterozygosity at 11q23.1 in breast carcinomas: Indication for involvement of a gene distal and close to ATM

Genes Chromosomes and Cancer

Volumn 18, Issue 3, 1997, Pages 175-180

  Laake, Kirsten ^a   Ødegård, Åse ^a   Andersen, Tone Ikdahl ^a   Bukholm, Ida K ^a   Kåresen, Rolf ^a   Nesland, Jahn M ^a   Ottestad, Lars ^a   Shiloh, Yosef ^b   Børresen Dale, Anne Lise ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST METASTASIS; CHROMOSOME 11Q; GENE LOCATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE DELETION; HETEROZYGOTE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0342697551     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199703)18:3<175::AID-GCC4>3.0.CO;2-Z     Document Type: Article

References (29)

1. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L, Børresen A-L (1993) Prognostic significance of TP53 alterations in breast carcinoma. Br J Cancer 68:540-548.
2. Bethwaite PB, Koreth J, Herrington CS, McGee JO'D (1995) Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. Br J Cancer 71:814-818.
3. Bhattacharya S, Wilson TME, Wojciechowski AP, Volpe CP, Scott J (1991) Hypervariable polymorphism in the APOC3 gene. Nucleic Acid Res 19:4799.
4. Bieche I, Lidereau R (1995) Genetic alterations in breast cancer. Genes Chromosom Cancer 14:227-251.
5. Børresen A-L, Andersen TI, Tretli S, Heiberg A, Møller P (1990) Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosom Cancer 2:339-340.
6. Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen A-L (1996) Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas. J Pathol (in press).
7. Carter SL, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF, Croce CM (1994) Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54:6270-6274.
8. Davis M, Hitchcock A, Foulkes WD, Campbell IG (1996) Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56:741-744.
9. Easton DF (1994) Cancer tisks in A-T heterozygotes. Int J Radiat Biol 66:177-182.
10. Gabra H, Taylor L, Cohen BB, Lessels A, Eccles DM, Leonard RCF, Smyth JF, Steel CM (1995) Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br J Cancer 72:367-375.
11. Gabra H, Watson JEV, Taylor KJ, Mackay J, Leonard RCF, Steel CM, Porteous DJ, Smyth JF (1996) Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56:950-954.
12. Gatti RA, McConville CM, Taylor AMR (1994) Sixth International Workshop on Ataxia-telangiectasia. Cancer Res 54:6007-6010.
13. Gustafson CE, Young J, Leggett B, Searle J, Chenevix-Trench G (1994) Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours. Br J Cancer 70:395-397.
14. Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newsham I, Cavenee WK, Evans GA (1994a) Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 1q23.3. Cancer Res 54:4586-4589.
15. Hampton GM, Penny LA, Baergen RN, Larson A, Brewer C, Liao S, Busby-Earle R MC, Williams AWR, Steel CM, Bird CC, Stanbridge EJ, Evans GA (1994b) Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. Proc Natl Acad Sci USA 91:6953-6957.
16. Harden DG (1994) The nature of ataxia-telangiectasia: Problems and perspectives. Int J Radiat Biol 66:13-19.
17. Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC (1995) A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res 55:2494-2496.
18. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WB, Croce CM (1995) Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3. Cancer Res 55:3003-3007.
19. Rotman G, Vanagaite L, Collins FS, Shiloh Y (1994) Three dinucleotide repeat polymorphisms at the ataxia-telangiectasia locus. Hum Mol Genet 3:2079.
20. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Yanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman TS, Lovett M, Collins FS, Shiloh Y (1995a) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753.
21. Savitskv K, Sfez S, Tagle DA, Ziv Y, Sartiel A, Collins FS, Shiloh Y, Rotman G (1995b) The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum Mol Genet 4:2025-2032.
22. Savitsky K, Ziv Y, Bar-Shira A, Gilad S, Tagle DA, Smith S, Uziel T, Sfez S, Nahmias J, Sartiel A, Eddy RL, Shows TB, Povey S, Collins FS, Shiloh Y, Rotman G (1996) A human gene encoding a putative DEAD-box RNA helicase at 11q22-23. Genomics 35:199-206.
23. Sedgwick RP, Boder E (1991) Ataxia-telangiectasia. In Vinken PJ, Bruyn GW, Klawans HL (eds): Handbook of Clinical Neurology, vol. 16. New York: Elsevier, pp 347-423.
24. Shiloh Y (1995) ataxia-telangiectasia: Closer to unraveling the mystery. Eur J Hum Genet 3:116-138.
25. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316:1289-1294.
26. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325:1831-1836.
27. Vanagaite L, Savitsky K, Rotman G, Ziv Y, Gerken SC, White R, Weissenbach J, Gillett G, Benham FJ, Richard III CW, James MR, Collins FS, Shiloh Y (1994) Physical localization of microsatellite markers at the ataxia-telangiectasia locus at 11q22-q23. Genomics 22:231-233.
28. Vanagaite L, James MR, Rotman G, Savitsky K, Bar-Shira A, Gilad S, Ziv Y, Uchenik V, Sartiel A, Collins FS, Sheffield VC, Richard CW III, Weissenbach J, Shiloh Y (1995) A high-density microsatellite map of the ataxia-telangiectasia locus. Hum Genet 95:451-454.
29. Winqvist R, Hampton A, Mannermaa A, Blanco G, Alavaikko M, Kiviniemi H, Taskinen PJ, Evans GA, Wright FA, Newsham I, Cavenee WK (1995) Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival alter metastasis. Cancer Res 55:2660-2664.